alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.1








CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER


PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





The undersigned, Dror Svorai, the Chief Executive Officer and Chief Financial Officer of InfoSpi, Inc., hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Quarterly Report on Form 10-Q of InfoSpi, Inc. for quarter ended September 30, 2010, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Quarterly Report on Amended Form 10-Q fairly presents in all material respects the financial condition and results of operations of InfoSpi, Inc.








DATE: February 16, 2011
By:
/s/Dror SvoraiName: Dror SvoraiTitle: Chief Executive Officer





By:
/s/Dror SvoraiName: Dror SvoraiTitle: Chief Financial Officer








A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to InfoSpi, Inc. and will be retained by InfoSpi, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
|T. | Rowe Price Tax-Free Income Fund, Inc.
|-- | -------------------------------------
|  
|T. | Rowe Price Tax-Free Income Fund      
|  

The following disclosure has been added as a type of security in which the fund may invest:

State and local governments may issue Build America Bonds to finance capital expenditures for which they otherwise could issue tax-exempt governmental bonds. Unlike most other municipal obligations, interest received on
Build America Bonds is taxable to the bondholder. These include bonds on which the issuer may receive an interest payment subsidy directly from the U.S. Treasury, known as direct pay Build America Bonds, and bonds on which the investor may receive a
tax credit, known as tax credit Build America Bonds.

---
[Federal Register Volume 73, Number 20 (Wednesday, January 30, 2008)]
[Notices]
[Pages 5498-5499]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-389]


-----------------------------------------------------------------------

DEPARTMENT OF AGRICULTURE

Forest Service


Notice of Meeting; Federal Lands Recreation Enhancement Act 
(Title VIII, Pub. L. 108-447)

AGENCY: USDA Forest Service.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Eastern Region Recreation Resource Advisory Committee will 
hold its third meeting via teleconference. The purpose of the meeting 
is to receive recommendations concerning recreation fee proposals on 
areas managed by the Forest Service in Michigan and to discuss other 
items of interest related to the Federal Lands Recreation Enhancement 
Act of 2004.
    A final detailed agenda, with any additions/corrections to agenda 
topics and meeting time, will be sent to regional media sources at 
least 14 days before the meeting, and hard copies can also be mailed or 
sent via FAX.

[[Page 5499]]

Individuals who need special assistance such as sign language 
interpretation or other reasonable accommodations, or who wish a hard 
copy of the agenda, should contact Marcia Heymen at 626 E. Wisconsin 
Ave., Milwaukee, WI 53202 no later than 10 days prior to the meeting.

DATES: The meeting will be held February 26, 2008.
    Send written comments to Cheryl Chatham, Designated Federal 
Official for the Eastern Recreation RAC, US Forest Service, PO Box 
1270, Hot Springs, AR 71902.

FOR FURTHER INFORMATION CONTACT: Cheryl Chatham, Designated Federal 
Official US Forest Service, PO Box 1270, Hot Springs, AR 71902.

SUPPLEMENTARY INFORMATION: The meeting is open to the public. Committee 
discussion is limited to Forest Service staff and Committee members. 
However, persons who wish to bring recreation fee matters to the 
attention of the Committee may file written statements with the 
Committee staff before or after the meeting. A public input session 
will be provided and individuals who made written requests by February 
20, 2008, will have the opportunity to address the Committee at the 
meeting.
    The Recreation RAC is authorized by the Federal Land Recreation 
Enhancement Act, which was signed into law by President Bush in 
December 2004.

    Dated: January 23, 2008.
Cheryl G. Chatham,
Designated Federal Officer.
[FR Doc. 08-389 Filed 1-29-08; 8:45 am]
BILLING CODE 3410-11-M
Draft Agenda 

Subcommittee for Dose Reconstruction and Site Profile Reviews 

(Advisory Board on Radiation and Worker Health) 

Hilton Cincinnati Netherlands Plaza 

Thursday – March 24, 2005 

12:00 p.m. – 12:15 p.m. 

12:15 p.m. – 12:45 p.m. 

12:45 p.m. – 2:30 p.m. 

2:30 p.m. – 2:45 p.m. 

2:45 p.m. – 4:30 p.m. 

4:30 p.m.

Friday – March 25, 2005 

8:30 a.m. – 8:45 a.m. 

 8:45 a.m. – 9:30 a.m. 

9:30 a.m. – 10:15 a.m. 

10:15 a.m. – 10:30 a.m. 

10:30 a.m. – 11:30 a.m. 

35 West 5th Street 

Cincinnati, Ohio 45202 

Phone: (513) 421-9100 

Fax: (513) 651-3195 

March 24-25, 2005 

Opening Remarks 

Review and Approval of 

 Draft Minutes, Meeting 3 

Subcommittee Discussion: 

- Scoring Methodology 

Break 

First 20 Dose Reconstructions: 

- Wrap Up 

Adjourn 

Opening Remarks 

Upcoming Set of 18 

 Dose Reconstruction 

 Reviews Status 

Subcommittee Discussion: 

- Bethlehem Steel Site Profile 

- How to Close 

Break 

Subcommittee Discussion: 

- Bethlehem Steel Site Profile 

- How to Close 

Dr. Lew Wade, Executive Secretary

 Dr. Paul Ziemer, Chair 

Dr. Paul Ziemer, Chair 

Members, Subcommittee 

Members, Subcommittee 

Dr. Lew Wade, Executive Secretary

 Dr. Paul Ziemer, Chair

John Mauro, SC&A 

11:30 a.m. Adjourn 

***Agenda Items are subject to change as priorities dictate***
Exhibit 32.2





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
1350



AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002





In connection with
the quarterly report of American Sands Energy Corp. (the “Company”) on Form 10-Q for the quarter ended June 30, 2012,
as filed with the Securities and Exchange Commission (the “Report”), the undersigned principal financial officer of
the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:



| | (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange
Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | the information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



Date: August 14, 2012







/s/ Daniel F. Carlson






Daniel F. Carlson, Chief Financial Officer

(Principal Financial Officer)
[Federal Register Volume 73, Number 6 (Wednesday, January 9, 2008)]
[Notices]
[Page 1634]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-51]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Aging Initial Review 
Group, Biological Aging Review Committee, NIA-B Committee Review 
Meeting.
    Date: February 7, 2008.
    Time: 11 a.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute on Aging, Gateway Building, 7201 
Wisconsin Avenue, Room 2C212, Bethesda, MD 20892, (Telephone 
Conference Call).
    Contact Person: Bita Nakhai, PhD, Scientific Review 
Administrator, Scientific Review Office, National Institute on 
Aging, Gateway Bldg., 2C212, 7201 Wisconsin Avenue, Bethesda, MD 
20814, 301-402-7701, <a href="/cdn-cgi/l/email-protection#0f616e64676e666d4f61666e2161666721686079"><span class="__cf_email__" data-cfemail="7719161c1f161e1537191e1659191e1f59101801">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)

    Dated: January 3, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-51 Filed 1-8-08; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
In the

Court of Appeals

Second Appellate District of Texas

at Fort Worth

No. 02-24-00145-CR

LARRY RAY CAPKO, Appellant

V.

THE STATE OF TEXAS

§

§

§

§

§

On Appeal from the 43rd District 

Court

of Parker County (CR22-0831)

May 30, 2024

Memorandum Opinion by Chief 

Justice Sudderth

(nfp)

JUDGMENT

This court has considered the record on appeal in this case and holds that the 

appeal should be dismissed. It is ordered that the appeal is dismissed.

SECOND DISTRICT COURT OF APPEALS 

By /s/ Bonnie Sudderth

 Chief Justice Bonnie Sudderth
<PAGE>

                                                                    Exhibit 23.2

                       CONSENT OF INDEPENDENT ACCOUNTANTS
                       ----------------------------------

     We hereby consent to the incorporation by reference in the Registration
Statements on Form S-8 (File Nos. 333-20033 and 333-71057) and Form S-3 (File
Nos. 333-33604, 333-37770, 333-73365 and 333-58217) of iGate Corporation of our
report dated February 4, 2003, except for Note 16 for which the date is February
26, 2003, relating to the financial statements, which appears in the Annual
Report to Shareholders, which is incorporated in this Annual Report on Form
10-K. We also consent to the incorporation by reference of our report dated
February 4, 2003 relating to the financial statement schedule, which appears in
this Form 10-K.

/s/ PRICEWATERHOUSECOOPERS

Pittsburgh, Pennsylvania
March 31,2003
# C_2011180EN.01000801.xml

| 21.6.2011 | EN | Official Journal of the European Union | C 180/8 |
| --- | --- | --- | --- |

21.6.2011

EN

Official Journal of the European Union

C 180/8

---

Non-opposition to a notified concentration

(Case COMP/M.6227 — Caisse des Dépôts et Consignations/Predica/Scor/SCI BRP 1)

(Text with EEA relevance)

2011/C 180/03

On 15 June 2011, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in French and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32011M6227. EUR-Lex is the on-line access to the European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32011M6227. EUR-Lex is the on-line access to the European law.

---
CONSENT OF INDEPENDENT ACCOUNTANTS

We consent to the incorporation by reference in the registration statement of
Paradise Music & Entertainment, Inc. on Form S-3 dated January 7, 1999 (file #
333-69581) and Form S-3 dated July 29, 1999 (file # 333-83517) of our report,
dated August 10, 1999 except for note 14 as to which the date is September 24,
1999 on our audits of the consolidated financial statements of Paradise Music &
Entertainment, Inc. as of June 30, 1999 and for the years ended June 30, 1999
and 1998.


                                        Rothstein, Kass & Company, P.C.
[Federal Register Volume 73, Number 13 (Friday, January 18, 2008)]
[Rules and Regulations]
[Page 3387]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-55500]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 1271


Human Cells, Tissues, and Cellular and Tissue-Based Products

CFR Correction

    In Title 21 of the Code of Federal Regulations, Parts 800 to 1299, 
revised as of April 1, 2007, in part 1271, on page 718, Sec.  1271.22 
is reinstated to read as follows:


Sec.  1271.22  How and where do I register and submit an HCT/P list?

    (a) You must use Form FDA 3356 for:
    (1) Establishment registration,
    (2) HCT/P listings, and
    (3) Updates of registration and HCT/P listing.
    (b) You may obtain Form FDA 3356:
    (1) By writing to the Center for Biologics Evaluation and Research 
(HFM-775), Food and Drug Administration, 1401 Rockville Pike, 
Rockville, MD 20852-1448, Attention: Tissue Establishment Registration 
Coordinator;
    (2) By contacting any Food and Drug Administration district office;
    (3) By calling the CBER Voice Information System at 1-800-835-4709 
or 301-827-1800; or
    (4) By connecting to http://www.fda.gov/opacom/morechoices/fdaforms/cber.html on the Internet.
    (c)(1) You may submit Form FDA 3356 to the Center for Biologics 
Evaluation and Research (HFM-775), Food and Drug Administration, 1401 
Rockville Pike, Rockville, MD 20852-1448, Attention: Tissue 
Establishment Registration Coordinator; or
    (2) You may submit Form FDA 3356 electronically through a secure 
web server at http://www.fda.gov/cber/tissue/tisreg.htm.

[69 FR 68681, Nov. 24, 2004]
[FR Doc. 08-55500 Filed 1-17-08; 8:45 am]
BILLING CODE 1505-01-D
I,  Andre Benard, the President, Chief Executive Officer and Chief Financial Officer of Calibert Explorations Ltd.. (the Registrant), certify that; (1)I have reviewed this Quarterly Report on Form 10-Q of the Registrant;(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;(4)I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934) for the Registrant and have:a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the Registrant is made known to me by others within those entities, particularly during the period in which this report is being prepared;b)Evaluated the effectiveness of the Registrants disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; andc)Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and(5)I have disclosed, based on my most recent evaluation of the internal control over financial reporting, to the Registrants auditors and the audit committee of Registrants board of directors (or persons performing the equivalent functions):a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrants ability to record, process, summarize and report financial information; andb)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrants internal control over financial reporting.  October 1, 2008/s/  Andre BenardBy:Andre BenardPresident, Chief Executive Officerand Chief Financial Officer
AGENDA

Advisory Board on Radiation and Worker Health 

Teleconference Meeting of the

Carborundum Work Group

August 18, 2016

Conference Call Number: 1-866-659-0537

Participant Pass Code: 9933701

10:00 a.m. Eastern Time

Welcome and roll-call

Discussion

• Brief Summary of DCAS Evaluation Report (ER) – Tom Tomes, NIOSH

• Review of ER and Findings – Bob Anigstein, SC@A

• Response to SC&A Findings -- Tom Tomes, NIOSH

• Petitioner Comments (optional)

• Next Steps and/or Recommendations to the Board

• Adjourn

Pertinent Papers

NIOSH Carborundum Company Special Exposure Cohort Petition Evaluation Report – June 3, 2015

SC&A Review of NIOSH ER and Carborundum Petition – January 27, 2016

NIOSH Response to SC&A Review – June 8, 2016

NIOSH Response on External Dose Assessment from X-Ray Diffraction – June 13, 2016

Issue Resolution Matrix for Carborundum Special Exposure Cohort Petition – June 5, 2016
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated balance sheet, consolidated statement of operations and
consolidated statement of cash flows included in the Company's Report for the
period ending November 30, 1997 and is qualified in its entirety by reference
to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          NOV-30-1997
<PERIOD-END>                               NOV-30-1997
<CASH>                                           2,739
<SECURITIES>                                    13,318
<RECEIVABLES>                                   11,023
<ALLOWANCES>                                       549
<INVENTORY>                                          0
<CURRENT-ASSETS>                                27,862
<PP&E>                                           3,220
<DEPRECIATION>                                   1,026
<TOTAL-ASSETS>                                  42,971
<CURRENT-LIABILITIES>                            5,157
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            47
<OTHER-SE>                                      37,246
<TOTAL-LIABILITY-AND-EQUITY>                    42,971
<SALES>                                              0
<TOTAL-REVENUES>                                26,910
<CGS>                                                0
<TOTAL-COSTS>                                   12,785
<OTHER-EXPENSES>                                10,749
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 873
<INCOME-PRETAX>                                  4,148
<INCOME-TAX>                                     1,768
<INCOME-CONTINUING>                              2,380
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,380
<EPS-PRIMARY>                                     0.41
<EPS-DILUTED>                                     0.41
        

</TABLE>
Motion Granted; Appeal Dismissed and Memorandum Opinion filed March

14, 2023

In The

Fourteenth Court of Appeals

NO. 14-23-00107-CV

METROPOLITAN WATER COMPANY, LP AND MET WATER VISTA 

RIDGE, LP, Appellants

V.

BLUE WATER SYSTEMS, LP AND BLUE WATER VISTA RIDGE, LLC, 

Appellees

On Appeal from the 21st District Court

Washington County, Texas

Trial Court Cause No. 37412

MEMORANDUM OPINION

This is an appeal from an order signed March 25, 2022. On February 28, 

2023, the parties filed a joint motion to dismiss the appeal. See Tex. R. App. P. 

42.1. The motion is granted. 
2

We dismiss the appeal.

PER CURIAM

Panel consists of Chief Justice Christopher and Justices Wise and Hassan.
1

COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

NOEL CASTILLO AND NORMA 

CASTILLO,

 

 Appellants,

v.

MARIA MARTINEZ,

 Appellee.

§

§

§

§

§

§

§

§

§

No. 08-22-00167-CV

Appeal from the

County Criminal Court No. 1

of El Paso County, Texas 

(TC# 2022-CCV00425)

O R D E R

The Court has received and filed the supplemental clerk’s record requested in this Court’s 

order issued on January 5, 2023. In an order signed on January 31, 2023, the trial court has 

overruled the contest filed by the Appellee to Appellant’s affidavit of indigency. The trial court 

further ordered the Appellant’s indigent and unable to pay court costs associated with the appeal. 

The appeal is reinstated. Appellee’s brief is now due March 11, 2023.

IT IS SO ORDERED this 9th day of February, 2023.

PER CURIAM

Before Rodriguez, C.J., Palafox and Soto, JJ.
Exhibit 13.2

CERTIFICATION                                            Pursuant
to 18 United States Code Section 1350,                                               As
adopted pursuant to Section 906 of the                                                      Sarbanes-Oxley
Act of 2002

The undersigned hereby
certifies that, to such officers knowledge, the Annual Report on Form 20-F for the
period ended December 31, 2003 of Net Serviços de Comunicação S.A. (the Company)
filed with the Securities and Exchange Commission on the date hereof fully complies with
the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and
that the information contained in such annual report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

| | /s/    Leonardo Porciúncula Gomes Pereira
| | -----------------------------------------
| |                                          
| | Name: Leonardo Porciúncula Gomes Pereira 
| | Title: Chief Financial Officer           
| | Date: June 30, 2004